356 related articles for article (PubMed ID: 28115739)
1. Genome-wide association study of therapeutic opioid dosing identifies a novel locus upstream of OPRM1.
Smith AH; Jensen KP; Li J; Nunez Y; Farrer LA; Hakonarson H; Cook-Sather SD; Kranzler HR; Gelernter J
Mol Psychiatry; 2017 Mar; 22(3):346-352. PubMed ID: 28115739
[TBL] [Abstract][Full Text] [Related]
2. Haplotypes at the OPRM1 locus are associated with susceptibility to substance dependence in European-Americans.
Luo X; Kranzler HR; Zhao H; Gelernter J
Am J Med Genet B Neuropsychiatr Genet; 2003 Jul; 120B(1):97-108. PubMed ID: 12815747
[TBL] [Abstract][Full Text] [Related]
3. A polymorphism in the OPRM1 3'-untranslated region is associated with methadone efficacy in treating opioid dependence.
Crist RC; Doyle GA; Nelson EC; Degenhardt L; Martin NG; Montgomery GW; Saxon AJ; Ling W; Berrettini WH
Pharmacogenomics J; 2018 Jan; 18(1):173-179. PubMed ID: 27958381
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide association study of opioid dependence: multiple associations mapped to calcium and potassium pathways.
Gelernter J; Kranzler HR; Sherva R; Koesterer R; Almasy L; Zhao H; Farrer LA
Biol Psychiatry; 2014 Jul; 76(1):66-74. PubMed ID: 24143882
[TBL] [Abstract][Full Text] [Related]
5. An intronic variant in OPRD1 predicts treatment outcome for opioid dependence in African-Americans.
Crist RC; Clarke TK; Ang A; Ambrose-Lanci LM; Lohoff FW; Saxon AJ; Ling W; Hillhouse MP; Bruce RD; Woody G; Berrettini WH
Neuropsychopharmacology; 2013 Sep; 38(10):2003-10. PubMed ID: 23612435
[TBL] [Abstract][Full Text] [Related]
6. Response to methadone maintenance treatment is associated with the MYOCD and GRM6 genes.
Fonseca F; Gratacòs M; Escaramís G; De Cid R; Martín-Santos R; Fernández-Espejo E; Estivill X; Torrens M
Mol Diagn Ther; 2010 Jun; 14(3):171-8. PubMed ID: 20560679
[TBL] [Abstract][Full Text] [Related]
7. Implications of OPRM1 and CYP2B6 variants on treatment outcomes in methadone-maintained patients in Ontario: Exploring sex differences.
Chawar C; Hillmer A; Lamri A; Kapczinski F; Thabane L; Pare G; Samaan Z
PLoS One; 2021; 16(12):e0261201. PubMed ID: 34910759
[TBL] [Abstract][Full Text] [Related]
8. Genome-wide Association Study Identifies a Regulatory Variant of RGMA Associated With Opioid Dependence in European Americans.
Cheng Z; Zhou H; Sherva R; Farrer LA; Kranzler HR; Gelernter J
Biol Psychiatry; 2018 Nov; 84(10):762-770. PubMed ID: 29478698
[TBL] [Abstract][Full Text] [Related]
9. Genomewide Gene-by-Sex Interaction Scans Identify ADGRV1 for Sex Differences in Opioid Dependent African Americans.
Yang BZ; Zhou H; Cheng Z; Kranzler HR; Gelernter J
Sci Rep; 2019 Dec; 9(1):18070. PubMed ID: 31792237
[TBL] [Abstract][Full Text] [Related]
10. κ Opioid Receptor 1 Single Nucleotide Polymorphisms were Associated with the Methadone Dosage.
Zhang Q; Shi M; Tang H; Zhong H; Lu X
Genet Test Mol Biomarkers; 2020 Jan; 24(1):17-23. PubMed ID: 31940240
[No Abstract] [Full Text] [Related]
11. Association of OPRM1 Functional Coding Variant With Opioid Use Disorder: A Genome-Wide Association Study.
Zhou H; Rentsch CT; Cheng Z; Kember RL; Nunez YZ; Sherva RM; Tate JP; Dao C; Xu K; Polimanti R; Farrer LA; Justice AC; Kranzler HR; Gelernter J;
JAMA Psychiatry; 2020 Oct; 77(10):1072-1080. PubMed ID: 32492095
[TBL] [Abstract][Full Text] [Related]
12. Effect of short-term prescription opioids on DNA methylation of the OPRM1 promoter.
Sandoval-Sierra JV; Salgado García FI; Brooks JH; Derefinko KJ; Mozhui K
Clin Epigenetics; 2020 Jun; 12(1):76. PubMed ID: 32493461
[TBL] [Abstract][Full Text] [Related]
13. The impact of OPRM1's genetic polymorphisms on methadone maintenance treatment in opioid addicts: a systematic review.
Oueslati B; Moula O; Ghachem R
Pharmacogenomics; 2018 Jun; 19(8):741-747. PubMed ID: 29785888
[TBL] [Abstract][Full Text] [Related]
14. Sex-specific linkage scans in opioid dependence.
Yang BZ; Han S; Kranzler HR; Palmer AA; Gelernter J
Am J Med Genet B Neuropsychiatr Genet; 2017 Apr; 174(3):261-268. PubMed ID: 27762075
[TBL] [Abstract][Full Text] [Related]
15. The μ-opioid receptor nonsynonymous variant 118A>G is associated with prolonged abstinence from heroin without agonist treatment.
Levran O; Peles E; Randesi M; da Rosa JC; Adelson M; Kreek MJ
Pharmacogenomics; 2017 Oct; 18(15):1387-1391. PubMed ID: 28976288
[TBL] [Abstract][Full Text] [Related]
16. Genome-wide association study of alcohol dependence:significant findings in African- and European-Americans including novel risk loci.
Gelernter J; Kranzler HR; Sherva R; Almasy L; Koesterer R; Smith AH; Anton R; Preuss UW; Ridinger M; Rujescu D; Wodarz N; Zill P; Zhao H; Farrer LA
Mol Psychiatry; 2014 Jan; 19(1):41-9. PubMed ID: 24166409
[TBL] [Abstract][Full Text] [Related]
17. A brief review of the genetics and pharmacogenetics of opioid use disorders.
Berrettini W
Dialogues Clin Neurosci; 2017 Sep; 19(3):229-236. PubMed ID: 29302220
[TBL] [Abstract][Full Text] [Related]
18. TAOK3, a novel genome-wide association study locus associated with morphine requirement and postoperative pain in a retrospective pediatric day surgery population.
Cook-Sather SD; Li J; Goebel TK; Sussman EM; Rehman MA; Hakonarson H
Pain; 2014 Sep; 155(9):1773-1783. PubMed ID: 24909733
[TBL] [Abstract][Full Text] [Related]
19. The role of hydromorphone and OPRM1 in postoperative pain relief with hydrocodone.
Boswell MV; Stauble ME; Loyd GE; Langman L; Ramey-Hartung B; Baumgartner RN; Tucker WW; Jortani SA
Pain Physician; 2013; 16(3):E227-35. PubMed ID: 23703421
[TBL] [Abstract][Full Text] [Related]
20. KAT2B polymorphism identified for drug abuse in African Americans with regulatory links to drug abuse pathways in human prefrontal cortex.
Johnson EO; Hancock DB; Levy JL; Gaddis NC; Page GP; Glasheen C; Saccone NL; Bierut LJ; Kral AH
Addict Biol; 2016 Nov; 21(6):1217-1232. PubMed ID: 26202629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
